Showing results (41-50 of 66) with videos related to
Sort By:
Pageof 7
Genetics|August 28, 2002
X chromosome effect on maternal recombination and meiotic drive in the mouseElena de La Casa-Esperón, J Concepción Loredo-Osti, Fernando Pardo-Manuel de Villena, et al.BMC Immunology|January 25, 2011
Evaluation of signal transduction pathways after transient cutaneous adenoviral gene deliveryLars Steinstraesser, Michael Sorkin, Frank Jacobsen, et al.American Journal of Physiology. Gastrointestinal and Liver Physiology|July 30, 2005
IL-28A and IL-29 mediate antiproliferative and antiviral signals in intestinal epithelial cells and murine CMV infection increases colonic IL-28A expressionStephan Brand, Florian Beigel, Torsten Olszak, et al.Annals of Hematology|November 17, 2022
Characteristics and outcomes of patients undergoing high-dose chemotherapy and autologous stem cell transplantation admitted to the intensive care unit: a single-center retrospective analysisJorge Garcia Borrega, Boris Böll, Matthias Kochanek, et al.European Journal of Haematology|June 27, 2024
Marked hyperferritinemia in critically ill cancer patientsPaul Liedgens, Jan-Michel Heger, Noelle Sieg, et al.European Journal of Haematology|May 7, 2021
Treatment patterns and disease course of previously untreated Primary Central Nervous System Lymphoma: Feasibility of MTX-based regimens in clinical routineNoëlle Sieg, Jan-Hendrik Naendrup, Philipp Gödel, et al.Inflammatory Bowel Diseases|January 9, 2007
Macrophage migration inhibitory factor (MIF) -173G/C promoter polymorphism influences upper gastrointestinal tract involvement and disease activity in patients with Crohn's diseaseJulia Dambacher, Tanja Staudinger, Julia Seiderer, et al.Proceedings of the National Academy of Sciences of the United States of America|December 5, 2019
Smad7 in intestinal CD4+ T cells determines autoimmunity in a spontaneous model of multiple sclerosisSteffen Haupeltshofer, Teresa Leichsenring, Sarah Berg, et al.European Journal of Haematology|September 3, 2022
JAK inhibition with ruxolitinib in relapsed or refractory classical Hodgkin lymphoma: Final results of a phase II, open label, multicentre clinical trial (JeRiCHO)Sarah Gillessen, Annette Pluetschow, Vladan Vucinic, et al.Physics in Medicine and Biology|March 12, 2024
First experimental time-of-flight-based proton radiography using low gain avalanche diodesFelix Ulrich-Pur, Thomas Bergauer, Tetyana Galatyuk, et al.Pageof 7